loadpatents
Patent applications and USPTO patent grants for Supuran; Claudiu.The latest application filed is for "novel sulfonamide compounds for inhibition of metastatic tumor growth".
Patent | Date |
---|---|
Sulfonamide compounds for inhibition of metastatic tumor growth Grant 9,962,398 - Supuran , et al. May 8, 2 | 2018-05-08 |
Treatment of mammalian disorders mediated by alpha-carbonic anhydrase isoforms Grant 9,623,025 - Supuran , et al. April 18, 2 | 2017-04-18 |
Novel Sulfonamide Compounds For Inhibition Of Metastatic Tumor Growth App 20170007627 - SUPURAN; Claudiu ;   et al. | 2017-01-12 |
Sulfonamide compounds for inhibition of metastatic tumor growth Grant 9,463,171 - Supuran , et al. October 11, 2 | 2016-10-11 |
Antibody to a carbonic anhydrase Grant 9,359,446 - Zeidler , et al. June 7, 2 | 2016-06-07 |
Cancer Targeting Using Carbonic Anhydrase Isoform Ix Inhibitors App 20150150849 - Lambin; Philippe ;   et al. | 2015-06-04 |
Cancer targeting using carbonic anhydrase isoform IX inhibitors Grant 8,980,932 - Lambin , et al. March 17, 2 | 2015-03-17 |
Carbonic Anhydrase Inhibitors With Antimetastatic Activity App 20140148400 - Supuran; Claudiu ;   et al. | 2014-05-29 |
CA IX-specific inhibitors Grant 8,628,771 - Supuran , et al. January 14, 2 | 2014-01-14 |
Cancer Targeting Using Carbonic Anhydrase Isoform Ix Inhibitors App 20130274305 - Lambin; Philippe ;   et al. | 2013-10-17 |
Novel Antibody To A Carbonic Anhydrase App 20130231465 - Zeidler; Reinhard ;   et al. | 2013-09-05 |
Novel Sulfonamide Compounds For Inhibition Of Metastatic Tumor Growth App 20130190396 - Supuran; Claudiu ;   et al. | 2013-07-25 |
Treatment Of Mammalian Disorders Mediated By Alpha-anhydrase Isoforms App 20120088776 - Supuran; Claudiu ;   et al. | 2012-04-12 |
CA IX-specific inhibitors Grant 7,833,738 - Supuran , et al. November 16, 2 | 2010-11-16 |
CA IX-specific inhibitors Grant 7,833,734 - Supuran , et al. November 16, 2 | 2010-11-16 |
CA IX-specific inhibitors Grant 7,833,514 - Supuran , et al. November 16, 2 | 2010-11-16 |
CA IX-specific inhibitors Grant 7,833,737 - Supuran , et al. November 16, 2 | 2010-11-16 |
CA IX-specific inhibitors Grant 7,833,739 - Supuran , et al. November 16, 2 | 2010-11-16 |
CA IX-specific inhibitors Grant 7,829,065 - Supuran , et al. November 9, 2 | 2010-11-09 |
CA IX-specific inhibitors Grant 7,550,424 - Supuran , et al. June 23, 2 | 2009-06-23 |
CA IX-Specific Inhibitors App 20080220001 - Supuran; Claudiu ;   et al. | 2008-09-11 |
CA IX-Specific Inhibitors App 20080213180 - Supuran; Claudiu ;   et al. | 2008-09-04 |
CA IX-Specific Inhibitors App 20080159955 - Supuran; Claudiu ;   et al. | 2008-07-03 |
CA IX-Specific Inhibitors App 20080145874 - Supuran; Claudiu ;   et al. | 2008-06-19 |
CA IX-Specific Inhibitors App 20080145877 - Supuran; Claudiu ;   et al. | 2008-06-19 |
CA IX-Specific Inhibitors App 20080146618 - Supuran; Claudiu ;   et al. | 2008-06-19 |
Ca Ix-specific Inhibitors App 20080095707 - Supuran; Claudiu ;   et al. | 2008-04-24 |
CA IX-specific inhibitors App 20060057068 - Supuran; Claudiu ;   et al. | 2006-03-16 |
CA IX-specific inhibitors App 20040146955 - Supuran, Claudiu ;   et al. | 2004-07-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.